These are exposure studies associated with the chemical and all of its children.
Reference | Associated Study Title | Author's Summary | Study Factors | Stressor | Receptors | Country | Medium | Exposure Marker | Measurements | Outcome | |
---|---|---|---|---|---|---|---|---|---|---|---|
1. | Loeb S, et al. (2015). | Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Trial | This study suggests that selenium supplements may reduce genetic risk of advanced prostate cancer, whereas aspirin, ibuprofen, and vegetables may reduce genetic risk of nonadvanced prostate cancer. | genetics | Aspirin | Ibuprofen | Selenium | Controls for disease:Prostatic Neoplasms | Subjects with disease:Prostatic Neoplasms | United States | Details | Prostatic Neoplasms |